Stem cell drugs surprise researchers: Could lead to better drugs in the future

curncman
Posts: 1312
Joined: Fri Jun 26, 2020 8:27 am

Single cell architecture of the immune microenvironment in lymphoma

Post by curncman »

Single cell architecture of the immune microenvironment in lymphoma

curncman
Posts: 1312
Joined: Fri Jun 26, 2020 8:27 am

Superbowl champ Billy Davis and Dr. Yoo AASCP seminar signature stem cells for NFL alumni referrals

Post by curncman »

Superbowl champ Billy Davis and Dr. Yoo AASCP seminar signature stem cells for NFL alumni referrals


curncman
Posts: 1312
Joined: Fri Jun 26, 2020 8:27 am

JADICELLS? - John's Rheumatoid Arthritis Stem Cell Therapy Review

Post by curncman »

John's Rheumatoid Arthritis Stem Cell Therapy Review

curncman
Posts: 1312
Joined: Fri Jun 26, 2020 8:27 am

History of Cancer Stem Cells

Post by curncman »

History of Cancer Stem Cells

curncman
Posts: 1312
Joined: Fri Jun 26, 2020 8:27 am

Rediscovering Interstitial Lung Diseases in the COVID 19 Era

Post by curncman »

Rediscovering Interstitial Lung Diseases in the COVID 19 Era



Role of Stem Cell in Disease Modelling and Cell Therapy | OPA Webinar Series

curncman
Posts: 1312
Joined: Fri Jun 26, 2020 8:27 am

Off-the-shelf iPSC therapies for solid tumors

Post by curncman »

Off-the-shelf iPSC therapies for solid tumors



curncman
Posts: 1312
Joined: Fri Jun 26, 2020 8:27 am

Regenerative medicine and stem cells

Post by curncman »





The Antibody Society
Last edited by curncman on Wed Dec 22, 2021 8:08 pm, edited 2 times in total.
curncman
Posts: 1312
Joined: Fri Jun 26, 2020 8:27 am

Sydney Coston - Using R Shiny to visualize stem cell treatment data over time

Post by curncman »

Sydney Coston - Using R Shiny to visualize stem cell treatment data over time

curncman
Posts: 1312
Joined: Fri Jun 26, 2020 8:27 am

New Patient Series: Blood & Marrow Transplants

Post by curncman »

New Patient Series: Blood & Marrow Transplants



curncman
Posts: 1312
Joined: Fri Jun 26, 2020 8:27 am

Folks Phase 3 trial is very tough

Post by curncman »

yesterday BridgeBio Pharma, Inc. (BBIO) lost 75% of its value yesterday for not meeting ts end points in Phase 3 trial yesterday

BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of cellular therapies for neurodegenerative diseases, BCLI is able to apply for Expanded Access Program (like RTT) which can be only granted with failed Phase 3 study (as of now)


Just wanted everyone to know how fortunate we are to have an OTC company like TSOI be in the league of BIGWIGS of Pharma industry and carving a niche for itself with innovative neutraceuticals and biologics!
Post Reply